Medtronic's MiniMed Group filed for a U.S. initial public offering on Friday, as the medical device maker moves ahead with ...

At present, around 59 million adults worldwide have diabetes, about 64 million are diagnosed with heart failure, and ...

Medtronic initially secured FDA clearance for the MiniMed 780G pump for people with Type 1 diabetes in early 2023. This past ...

How a reporter began to investigate diabetes risk, and along the way, made a startling discovery about his own health.

Gut microbes produce a molecule that switches off inflammation linked to diabetes, offering a surprising new path to ...

Our cells follow 24-hour circadian rhythms that regulate our blood sugar levels and are heavily influenced by light exposure.

Five diabetes subgroups (MARD, MOD, SAID, SIDD, SIRD) have specific comorbidity and mortality risk profiles, study results show.

A recent Cleveland Clinic study used AI to create digital twins of patients' metabolisms—and cured 7 in 10 type 2 diabetics.

Scientists found that certain molecules made by gut bacteria travel to the liver and help control how the body uses energy.

Tenofovir alafenamide (Vemlidy) for the initial treatment of chronic hepatitis B may confer modestly higher rates of complete ...

Scientists at the University of Wisconsin–Madison have uncovered a possible way to protect key cells in the pancreas that are ...

MiniMed Group Inc., a diabetes management firm that will be separated from health care giant Medtronic Plc, filed for an ...